Product Reports Resources Pricing Login Book a demo
Kevin Bitterman
Person profile

Kevin Bitterman

LinkedIn
2 schools
Education

Currently

Active roles, board seats and partnerships.

Judo Bio
Board of Directors · 2022 – present
→
Kinaset Therapeutics
Board Member · 2020 – present
→
Chroma Medicine
2020 – present
→
nChroma Bio
Board of Directors · 2020 – present
→
Vedere Bio
2019 – present
→
Remix Therapeutics
Board Member · 2019 – present
→
Atlas Venture
Partner · 2017 – present
venture_capital
→
Disc Medicine
Board Member · 2017 – present
→
Isabella Stewart Gardner Museum
Member Board of Trustees · 2017 – present
→
Follica
Director
→

Work history

Past roles by Dealroom records.

Mariana Oncology
Board Member · 2021 – 2024
→
Akero Therapeutics
Board Member · 2018 – 2021
→
Navitor
Board Member · 2017 – 2020
→
Morphic Therapeutic
Board Member · CEO · 2014 – 2017
→
Editas Medicine
Board Member · CEO · 2013 – 2018
→
New England Venture Capital Association
Board Member · Chairman of the Board · 2013 – 2023
→
Vets First Choice
Board Member · 2012 – 2017
→
Neuronetics
Board Member · 2011 – 2017
→
InSeal Medical
Board Member · 2009 – 2017
→
KALA BIO
Board Member · 2009 – 2017
→
Visterra
Board Member · 2009 – 2015
→
TARIS Biomedical
Board Member · 2008 – 2017
→
Genocea Biosciences
Board Member · 2006 – 2017
→
Polaris Partners
Partner · 2004 – 2017
private_equity, venture_capital
→
Biolex Therapeutics
Director
→

Education

PhD · 1980 – 2004
Bachelor · 1995 – 1999
← All people